$OXFD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oxford Immunotec Global PLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Oxford Immunotec Global PLC. Get notifications about new insider transactions in Oxford Immunotec Global PLC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 12.96 | 9,494 | 123,042 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 14.17 | 7,457 | 105,666 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 16.86 | 7,457 | 125,725 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 15.40 | 14,914 | 229,676 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 15.40 | 7,457 | 114,838 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 14.44 | 7,457 | 107,679 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 14.49 | 7,457 | 108,052 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 14.46 | 7,457 | 107,828 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 8.65 | 7,457 | 64,503 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Sell | D | 22.00 | 4,081 | 89,782 | 0 | 4.1 K to 0 (-100.00 %) | |
Mar 12 2021 | OXFD | Oxford Immunotec G ... | McLaughlin Matthew T E | Chief Financial Off ... | Option Exercise | D | 12.19 | 34,795 | 424,151 | 0 | |
Mar 12 2021 | OXFD | Oxford Immunotec G ... | McLaughlin Matthew T E | Chief Financial Off ... | Option Exercise | D | 15.97 | 32,064 | 512,062 | 0 | |
Mar 12 2021 | OXFD | Oxford Immunotec G ... | McLaughlin Matthew T E | Chief Financial Off ... | Option Exercise | D | 15.97 | 25,044 | 399,953 | 0 | |
Mar 12 2021 | OXFD | Oxford Immunotec G ... | McLaughlin Matthew T E | Chief Financial Off ... | Sell | D | 22.00 | 61,407 | 1,350,954 | 0 | 61.4 K to 0 (-100.00 %) |
Mar 12 2021 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Option Exercise | D | 12.96 | 9,494 | 123,042 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Option Exercise | D | 14.44 | 7,457 | 107,679 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Option Exercise | D | 14.49 | 7,457 | 108,052 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Option Exercise | D | 14.46 | 7,457 | 107,828 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Option Exercise | D | 8.65 | 6,107 | 52,826 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Option Exercise | D | 14.17 | 7,457 | 105,666 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Option Exercise | D | 16.86 | 7,457 | 125,725 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Sell | D | 22.00 | 4,081 | 89,782 | 0 | 4.1 K to 0 (-100.00 %) | |
Mar 12 2021 | OXFD | Oxford Immunotec G ... | Klausner Mark R. | Option Exercise | D | 12.96 | 9,494 | 123,042 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | Klausner Mark R. | Option Exercise | D | 14.44 | 7,457 | 107,679 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | Klausner Mark R. | Option Exercise | D | 14.49 | 7,457 | 108,052 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | Klausner Mark R. | Option Exercise | D | 10.93 | 14,914 | 163,010 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | Klausner Mark R. | Option Exercise | D | 10.93 | 3,728 | 40,747 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | Klausner Mark R. | Sell | D | 22.00 | 4,081 | 89,782 | 0 | 4.1 K to 0 (-100.00 %) | |
Mar 12 2021 | OXFD | Oxford Immunotec G ... | Kidd Janet Louise | General Counsel | Option Exercise | D | 16.73 | 23,290 | 389,642 | 0 | |
Mar 12 2021 | OXFD | Oxford Immunotec G ... | Kidd Janet Louise | General Counsel | Sell | D | 22.00 | 11,207 | 246,554 | 0 | 11.2 K to 0 (-100.00 %) |
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Option Exercise | D | 12.96 | 9,494 | 123,042 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Option Exercise | D | 14.17 | 7,457 | 105,666 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Option Exercise | D | 16.86 | 7,457 | 125,725 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Option Exercise | D | 16.86 | 14,914 | 251,450 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Option Exercise | D | 14.44 | 7,457 | 107,679 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Option Exercise | D | 14.49 | 7,457 | 108,052 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Option Exercise | D | 14.46 | 7,457 | 107,828 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Option Exercise | D | 8.65 | 7,457 | 64,503 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Option Exercise | D | 0.18 | 10,310 | 1,856 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Option Exercise | D | 0.81 | 11,931 | 9,664 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Sell | D | 22.00 | 27,805 | 611,710 | 0 | 27.8 K to 0 (-100.00 %) | |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 12.96 | 9,494 | 123,042 | 9,494 | |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Grant | A | 0.00 | 4,081 | 0 | 4,081 | 0 to 4.1 K |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | BALTHROP PATRICK J | Director | Option Exercise | A | 12.96 | 9,494 | 123,042 | 9,494 | |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | BALTHROP PATRICK J | Director | Grant | A | 0.00 | 4,081 | 0 | 4,081 | 0 to 4.1 K |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | A | 12.96 | 9,494 | 123,042 | 9,494 | |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Grant | A | 0.00 | 4,081 | 0 | 4,081 | 0 to 4.1 K |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | TOBIN JAMES R | Director | Option Exercise | A | 12.96 | 9,494 | 123,042 | 9,494 | |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | TOBIN JAMES R | Director | Grant | A | 0.00 | 4,081 | 0 | 4,081 | 0 to 4.1 K |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | Walton Andrew Scott | Director | Option Exercise | A | 12.96 | 9,494 | 123,042 | 9,494 | |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | Walton Andrew Scott | Director | Grant | A | 0.00 | 4,081 | 0 | 4,081 | 0 to 4.1 K |
May 21 2020 | OXFD | Oxford Immunotec G ... | BALTHROP PATRICK J | Director | Buy | P | 12.48 | 4,000 | 49,920 | 4,000 | 0 to 4 K |
May 12 2020 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | P | 11.56 | 15,525 | 179,469 | 400,225 | 384.7 K to 400.2 K (+4.04 %) |
May 12 2020 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | P | 11.45 | 26,000 | 297,700 | 384,700 | 358.7 K to 384.7 K (+7.25 %) |
May 12 2020 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | P | 10.75 | 2,075 | 22,306 | 358,700 | 356.6 K to 358.7 K (+0.58 %) |
Mar 13 2020 | OXFD | Oxford Immunotec G ... | McLaughlin Matthew T E | Chief Financial Off ... | Option Exercise | A | 12.19 | 34,795 | 424,151 | 34,795 | |
Mar 13 2020 | OXFD | Oxford Immunotec G ... | McLaughlin Matthew T E | Chief Financial Off ... | Grant | A | 0.00 | 34,795 | 0 | 61,407 | 26.6 K to 61.4 K (+130.75 %) |
Mar 13 2020 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Option Exercise | M | 0.09 | 15,074 | 1,357 | 0 | |
Mar 13 2020 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Buy | M | 0.09 | 15,074 | 1,357 | 23,724 | 8.7 K to 23.7 K (+174.27 %) |
Mar 13 2020 | OXFD | Oxford Immunotec G ... | Linn Stefan C | Chief Operating Off ... | Option Exercise | A | 12.19 | 37,235 | 453,895 | 37,235 | |
Mar 13 2020 | OXFD | Oxford Immunotec G ... | Linn Stefan C | Chief Operating Off ... | Grant | A | 0.00 | 37,235 | 0 | 96,301 | 59.1 K to 96.3 K (+63.04 %) |
Nov 20 2019 | OXFD | Oxford Immunotec G ... | Kidd Janet Louise | General Counsel | Option Exercise | A | 16.73 | 25,612 | 428,489 | 25,612 | |
Nov 20 2019 | OXFD | Oxford Immunotec G ... | Kidd Janet Louise | General Counsel | Grant | A | 0.00 | 11,207 | 0 | 11,207 | 0 to 11.2 K |
Nov 05 2019 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | M | 8.65 | 1,350 | 11,678 | 6,107 | |
Nov 05 2019 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | M | 0.09 | 1,650 | 149 | 0 | |
Nov 05 2019 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 15.60 | 3,000 | 46,800 | 0 | 3 K to 0 (-100.00 %) |
Nov 05 2019 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Buy | M | 8.65 | 1,350 | 11,678 | 3,000 | 1.7 K to 3 K (+81.82 %) |
Nov 05 2019 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Buy | M | 0.09 | 1,650 | 149 | 1,650 | 0 to 1.7 K |
Oct 03 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.21 | 30,000 | 486,402 | 294,538 | 324.5 K to 294.5 K (-9.24 %) |
Sep 25 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 17.01 | 80,000 | 1,361,096 | 324,538 | 404.5 K to 324.5 K (-19.78 %) |
Sep 25 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 14.92 | 20,000 | 298,366 | 404,538 | 424.5 K to 404.5 K (-4.71 %) |
Aug 20 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 13.86 | 10,000 | 138,647 | 424,538 | 434.5 K to 424.5 K (-2.30 %) |
Aug 05 2019 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 19.90 | 3,000 | 59,703 | 0 | 3 K to 0 (-100.00 %) |
Jun 19 2019 | OXFD | Oxford Immunotec G ... | Walton Andrew Scott | Director | Option Exercise | A | 14.44 | 7,457 | 107,679 | 7,457 | |
Jun 19 2019 | OXFD | Oxford Immunotec G ... | TOBIN JAMES R | Director | Option Exercise | A | 14.44 | 7,457 | 107,679 | 7,457 | |
Jun 19 2019 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | A | 14.44 | 7,457 | 107,679 | 7,457 | |
Jun 19 2019 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 14.44 | 7,457 | 107,679 | 7,457 | |
Jun 19 2019 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Option Exercise | A | 14.44 | 7,457 | 107,679 | 7,457 | |
Jun 19 2019 | OXFD | Oxford Immunotec G ... | Klausner Mark R. | Director | Option Exercise | A | 14.44 | 7,457 | 107,679 | 7,457 | |
Jun 19 2019 | OXFD | Oxford Immunotec G ... | BALTHROP PATRICK J | Director | Option Exercise | A | 14.44 | 7,457 | 107,679 | 7,457 | |
Jun 19 2019 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 14.44 | 7,457 | 107,679 | 7,457 | |
Apr 10 2019 | OXFD | Oxford Immunotec G ... | McLaughlin Matthew T E | Chief Financial Off ... | Option Exercise | A | 15.97 | 57,108 | 912,015 | 57,108 | |
Apr 10 2019 | OXFD | Oxford Immunotec G ... | McLaughlin Matthew T E | Chief Financial Off ... | Grant | A | 0.00 | 26,612 | 0 | 26,612 | 0 to 26.6 K |
Apr 03 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 16.42 | 67,959 | 1,115,887 | 67,959 | |
Apr 03 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 17.21 | 600 | 10,326 | 434,538 | 435.1 K to 434.5 K (-0.14 %) |
Apr 03 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.64 | 10,000 | 166,446 | 435,138 | 445.1 K to 435.1 K (-2.25 %) |
Apr 03 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 31,669 | 0 | 445,138 | 413.5 K to 445.1 K (+7.66 %) |
Apr 03 2019 | OXFD | Oxford Immunotec G ... | Linn Stefan C | Chief Operating Off ... | Option Exercise | A | 16.42 | 44,853 | 736,486 | 44,853 | |
Apr 03 2019 | OXFD | Oxford Immunotec G ... | Linn Stefan C | Chief Operating Off ... | Grant | A | 0.00 | 20,901 | 0 | 59,066 | 38.2 K to 59.1 K (+54.76 %) |
Mar 06 2019 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | SVP & General Couns ... | Sell | S | 17.00 | 4,100 | 69,712 | 26,928 | 31 K to 26.9 K (-13.21 %) |
Feb 20 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.99 | 10,000 | 169,934 | 413,469 | 423.5 K to 413.5 K (-2.36 %) |
Feb 01 2019 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.25 | 3,000 | 42,751 | 6,000 | 9 K to 6 K (-33.33 %) |
Jan 11 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 14.91 | 10,000 | 149,073 | 423,469 | 433.5 K to 423.5 K (-2.31 %) |
Jan 03 2019 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | SVP & General Couns ... | Payment of Exercise | F | 12.78 | 816 | 10,428 | 31,028 | 31.8 K to 31 K (-2.56 %) |
Jan 03 2019 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | SVP & General Couns ... | Payment of Exercise | F | 12.78 | 789 | 10,083 | 31,844 | 32.6 K to 31.8 K (-2.42 %) |
Nov 01 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 15.50 | 3,000 | 46,500 | 9,000 | 12 K to 9 K (-25.00 %) |
Oct 03 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.93 | 10,000 | 169,260 | 433,469 | 443.5 K to 433.5 K (-2.25 %) |
Oct 03 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.50 | 10,000 | 165,000 | 443,469 | 453.5 K to 443.5 K (-2.21 %) |
Sep 27 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 54,273 | 43,961 | 0 | |
Sep 27 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 18.92 | 46,100 | 872,064 | 453,469 | 499.6 K to 453.5 K (-9.23 %) |
Sep 27 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 17.84 | 40,000 | 713,704 | 499,569 | 539.6 K to 499.6 K (-7.41 %) |
Sep 27 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 54,273 | 43,961 | 539,569 | 485.3 K to 539.6 K (+11.18 %) |
Sep 10 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 40,000 | 32,400 | 54,273 | |
Sep 10 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 14.95 | 40,000 | 598,000 | 485,296 | 525.3 K to 485.3 K (-7.61 %) |
Sep 10 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 40,000 | 32,400 | 525,296 | 485.3 K to 525.3 K (+8.24 %) |
Aug 03 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.15 | 3,000 | 39,450 | 12,000 | 15 K to 12 K (-20.00 %) |
Jun 21 2018 | OXFD | Oxford Immunotec G ... | Walton Andrew Scott | Director | Option Exercise | A | 14.49 | 7,457 | 108,052 | 7,457 | |
Jun 21 2018 | OXFD | Oxford Immunotec G ... | TOBIN JAMES R | Director | Option Exercise | A | 14.49 | 7,457 | 108,052 | 7,457 | |
Jun 21 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | A | 14.49 | 7,457 | 108,052 | 7,457 | |
Jun 21 2018 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 14.49 | 7,457 | 108,052 | 7,457 | |
Jun 21 2018 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Option Exercise | A | 14.49 | 7,457 | 108,052 | 7,457 | |
Jun 21 2018 | OXFD | Oxford Immunotec G ... | Klausner Mark R. | Director | Option Exercise | A | 14.49 | 7,457 | 108,052 | 7,457 | |
Jun 21 2018 | OXFD | Oxford Immunotec G ... | BALTHROP PATRICK J | Director | Option Exercise | A | 14.49 | 7,457 | 108,052 | 7,457 | |
Jun 21 2018 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 14.49 | 7,457 | 108,052 | 7,457 | |
Jun 14 2018 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | SVP & General Couns ... | Payment of Exercise | F | 14.41 | 2,500 | 36,025 | 32,633 | 35.1 K to 32.6 K (-7.12 %) |
May 02 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | M | 0.09 | 3,000 | 270 | 1,650 | |
May 02 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 12.77 | 3,000 | 38,304 | 15,000 | 18 K to 15 K (-16.67 %) |
May 02 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Buy | M | 0.09 | 3,000 | 270 | 18,000 | 15 K to 18 K (+20.00 %) |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Linn Stefan C | Chief Operating Off ... | Option Exercise | A | 13.24 | 24,637 | 326,194 | 24,637 | |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Linn Stefan C | Chief Operating Off ... | Grant | A | 0.00 | 5,634 | 0 | 38,165 | 32.5 K to 38.2 K (+17.32 %) |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Option Exercise | A | 13.24 | 34,661 | 458,912 | 34,661 | |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Grant | A | 0.00 | 7,926 | 0 | 210,891 | 203 K to 210.9 K (+3.91 %) |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Wenstrup Richard | Chief Medical Offic ... | Option Exercise | A | 13.24 | 19,112 | 253,043 | 19,112 | |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Wenstrup Richard | Chief Medical Offic ... | Grant | A | 0.00 | 4,370 | 0 | 22,992 | 18.6 K to 23 K (+23.47 %) |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 13.24 | 103,330 | 1,368,089 | 103,330 | |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 23,628 | 0 | 485,296 | 461.7 K to 485.3 K (+5.12 %) |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | Senior VP & General ... | Option Exercise | A | 13.24 | 47,587 | 630,052 | 47,587 | |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | Senior VP & General ... | Grant | A | 0.00 | 10,882 | 0 | 35,133 | 24.3 K to 35.1 K (+44.87 %) |
Mar 02 2018 | OXFD | Oxford Immunotec G ... | Klausner Mark R. | Director | Option Exercise | A | 10.93 | 14,914 | 163,010 | 14,914 | |
Mar 02 2018 | OXFD | Oxford Immunotec G ... | Klausner Mark R. | Director | Option Exercise | A | 10.93 | 3,728 | 40,747 | 3,728 | |
Feb 16 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | M | 0.09 | 2,500 | 225 | 4,650 | |
Feb 16 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | M | 0.09 | 500 | 45 | 7,150 | |
Feb 16 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 12.02 | 2,500 | 30,038 | 15,000 | 17.5 K to 15 K (-14.29 %) |
Feb 16 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Buy | M | 0.09 | 2,500 | 225 | 17,500 | 15 K to 17.5 K (+16.67 %) |
Feb 16 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 12.00 | 500 | 6,000 | 15,000 | 15.5 K to 15 K (-3.23 %) |
Feb 16 2018 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Buy | M | 0.09 | 500 | 45 | 15,500 | 15 K to 15.5 K (+3.33 %) |
Jan 26 2018 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Option Exercise | M | 0.18 | 152,330 | 27,419 | 0 | |
Jan 26 2018 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Buy | M | 0.18 | 152,330 | 27,419 | 202,965 | 50.6 K to 203 K (+300.84 %) |
Jan 03 2018 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | Senior VP & General ... | Payment of Exercise | F | 13.97 | 1,142 | 15,954 | 24,251 | 25.4 K to 24.3 K (-4.50 %) |
Jan 03 2018 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Payment of Exercise | F | 13.97 | 1,480 | 20,676 | 50,635 | 52.1 K to 50.6 K (-2.84 %) |
Jan 03 2018 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Payment of Exercise | F | 13.97 | 778 | 10,869 | 52,115 | 52.9 K to 52.1 K (-1.47 %) |
Nov 02 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | M | 0.09 | 222 | 20 | 7,650 | |
Nov 02 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | M | 0.81 | 2,778 | 2,250 | 0 | |
Nov 02 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 13.35 | 3,000 | 40,050 | 15,000 | 18 K to 15 K (-16.67 %) |
Nov 02 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Buy | M | 0.09 | 222 | 20 | 18,000 | 17.8 K to 18 K (+1.25 %) |
Nov 02 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Buy | M | 0.81 | 2,778 | 2,250 | 17,778 | 15 K to 17.8 K (+18.52 %) |
Oct 04 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 55,000 | 44,550 | 94,273 | |
Oct 04 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.78 | 55,000 | 922,933 | 461,668 | 516.7 K to 461.7 K (-10.65 %) |
Oct 04 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 55,000 | 44,550 | 516,668 | 461.7 K to 516.7 K (+11.91 %) |
Sep 05 2017 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | M | 0.81 | 3,000 | 2,430 | 2,778 |